Issue 2/2024
Content (19 Articles)
Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response
Samuel A. Bobholz, Alisha Hoefs, Jordyn Hamburger, Allison K. Lowman, Aleksandra Winiarz, Savannah R. Duenweg, Fitzgerald Kyereme, Jennifer Connelly, Dylan Coss, Max Krucoff, Anjishnu Banerjee, Peter S. LaViolette
Correction to: Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response
Samuel A. Bobholz, Alisha Hoefs, Jordyn Hamburger, Allison K. Lowman, Aleksandra Winiarz, Savannah R. Duenweg, Fitzgerald Kyereme, Jennifer Connelly, Dylan Coss, Max Krucoff, Anjishnu Banerjee, Peter S. LaViolette
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk–benefit analysis
Obada T. Alhalabi, Philip Dao Trong, Manuel Kaes, Martin Jakobs, Tobias Kessler, Hannah Oehler, Laila König, Tanja Eichkorn, Felix Sahm, Jürgen Debus, Andreas von Deimling, Wolfgang Wick, Antje Wick, Sandro M. Krieg, Andreas W. Unterberg, Christine Jungk
The role of spine stereotactic radiosurgery for patients with breast cancer metastases
Suchet Taori, Samuel Adida, Anthony Tang, Akshath Rajan, Roberta K. Sefcik, Steven A. Burton, John C. Flickinger, Pascal O. Zinn, Peter C. Gerszten
Repeated surgical resections for management of high-grade glioma and its impact on quality of life
Jun Min Koay, Loizos Michaelides, Diogo P. Moniz-Garcia, Alfredo Quinones-Hinojosa, Kaisorn Chaichana, Joao Paulo Almeida, Benjamin F. Gruenbaum, Wendy J. Sherman, David S. Sabsevitz
Utility of molecular markers in predicting local control specific to lung cancer spine metastases treated with stereotactic body radiotherapy
Dana Shor, Alexander V. Louie, Kang Liang Zeng, Ines B. Menjak, Eshetu G. Atenafu, Chia-Lin Tseng, Jay Detsky, Jeremie Larouche, Beibei Zhang, Hany Soliman, Sten Myrehaug, Pejman Maralani, David M. Hwang, Arjun Sahgal, Hanbo Chen
Prognostic factors analysis of diffuse midline glioma
Jing Jiang, Wen-bin Li, Shao-wen Xiao
Correction to: Prognostic factors analysis of diffuse midline glioma
Jing Jiang, Wen-bin Li, Shao-wen Xiao
Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center
Melek Tugce Yilmaz, Alper Kahvecioglu, Gozde Yazici, Sepideh Mohammadipour, Neyran Kertmen, Gokcen Coban Cifci, Faruk Zorlu
The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study
Meimei Yu, Ying Ge, Zixuan Wang, Yang Zhang, Xinyi Hou, Hongyan Chen, Xuzhu Chen, Nan Ji, Xin Li, Huicong Shen
Diverse learners: learning disabilities and quality of life following mind–body and health education interventions for adults with neurofibromatosis
Millan R. Kanaya, Jonathan Greenberg, Jafar Bakhshaie, Ana-Maria Vranceanu
Palliative care for in-patient malignant glioma patients in Germany
Larissa Fink, Birgitt van Oorschot, Christiane von Saß, Maxine Dibué, Marie-Therese Foster, Heidrun Golla, Ronald Goldbrunner, Christian Senft, Aaron Lawson McLean, Martin Hellmich, Nazife Dinc, Raymond Voltz, Heiner Melching, Christine Jungk, Marcel A. Kamp
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma
Phioanh Leia Nghiemphu, Jeremie Vitte, Eva Dombi, Thien Nguyen, Naveed Wagle, Akira Ishiyama, Ali R. Sepahdari, David Cachia, Brigitte C. Widemann, Derald E. Brackmann, Joni K. Doherty, Michel Kalamarides, Marco Giovannini
Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors
James L. Rogers, Thomas Wall, Alvina A. Acquaye-Mallory, Lisa Boris, Yeonju Kim, Kenneth Aldape, Martha M. Quezado, John A. Butman, James G. Smirniotopoulos, Huma Chaudhry, Christina I. Tsien, Prashant Chittiboina, Kareem Zaghloul, Orwa Aboud, Nicholas G. Avgeropoulos, Eric C. Burton, David M. Cachia, Karan S. Dixit, Jan Drappatz, Erin M. Dunbar, Peter Forsyth, Edina Komlodi-Pasztor, Jacob Mandel, Byram H. Ozer, Eudocia Q. Lee, Surabhi Ranjan, Rimas V. Lukas, Margarita Raygada, Michael E. Salacz, Matthew A. Smith-Cohn, James Snyder, Ariane Soldatos, Brett J. Theeler, Brigitte C. Widemann, Kevin A. Camphausen, John D. Heiss, Terri S. Armstrong, Mark R. Gilbert, Marta Penas-Prado
Comment: Additional factors affecting cognitive function in low grade glioma patients
Polina Angelova, Maria Gicheva
Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis
Peter G. Zaki, Sanjeev Herr, Matthew J. Shepard
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence
Mohamed Jalloh, Samuel Berchi Kankam
Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy
Carrie E. Andrews, Jenny Zilberberg, Raul Perez-Olle, Mark A. Exley, David W. Andrews
Correction to: Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study
Ko-Ting Chen, Chiung-Yin Huang, Ping-Ching Pai, Wen-Chi Yang, Chen-Kan Tseng, Hong-Chieh Tsai, Jui-Chin Li, Chi-Cheng Chuang, Peng-Wei Hsu, Cheng-Chi Lee, Cheng-Hong Toh, Hao-Li Liu, Kuo-Chen Wei